Answers are grounded in this paper and cite their sources.
A major priority for funding agencies and researchers involved in comparative-effectiveness research (CER) is to ensure that research questions will produce findings that are relevant and feasible to implement. In this article, we describe a process for involving experts and stakeholders in identifying and prioritizing CER studies, as illustrated by our experience in chronic obstructive pulmonary disease (COPD). Clinical Pharmacology & Therapeutics (2011); 90 6, 888–892. doi:10.1038/clpt.2011.237
No takes yet. Share an insight, caveat, or question.
Pickard et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: